This content aligns with Goal 3: Good Health and Wellbeing and Goal 9: Industry, Innovation, and Infrastructure by considering the role heavy metals such as lead, mercury, and cadmium can play in Alzheimer's Disease.
This chapter explores ethical challenges in the research, development, and commercialization of neural interfaces, aligning with SDG 3 (Good Health and Well-being) by ensuring safe and responsible innovation in neurotechnology, SDG 9 (Industry, Innovation, and Infrastructure) through fostering ethical advancement in cutting-edge technologies, and SDG 10 (Reduced Inequalities) by addressing issues of distributive justice and equitable access to emerging neurotechnologies.
International Day of the World's Indigenous Peoples is an annual celebration on August 9th. To raise awareness for this important topic, Elsevier presents a curated list of publicly available journal articles and book chapters to help advance #SDG16 research.
Ceria nanoclusters, with their ultra-small particle size and and targeted peptides, provides substantial penetration of the blood drain barrier for rapid and susptained relief from neuroinflammation.
Given the climate crisis, all sectors must make choices that serve people and planet well into the future. The establishment of the United Nations Sustainable Development Goals (SDGs) in 2015 shifted the global debates on these issues particularly recognizing that sustainability as a critical lens must be applied not only by public and not-for-profit sectors, but also by philanthropy and private sector.
